Sade-Feldman Lab

Sade-Feldman Lab
Translational Cancer Immunology Lab
Krantz Family Center for Cancer Research @MGHCancerCenter
Cancer immunology, Resistance to immunotherapy

[Sade-Feldman Lab @Sade_Lab_TCI]

Lab website:
https://t.co/8g5W7NRJ1N

[Genevieve Boland, MD, PhD @gmboland]

Excited to welcome @amandakirane to @MGHSurgery via the @SocSurgOnc Career Catalyst Program. Kicking off with an @MGH_WiO breakfast in the Healing Garden @SophiaKMcKinley @kreynoldsMD

[Michael Birnbaum @MEBirnbaum]

My department (MIT Biological Engineering) is hiring at the Assistant Professor level! We are looking for someone in immunology/immunotherapy/immune engineering, broadly defined. https://t.co/F5fyVKSsTs

[Cancer Immunology Research @CIR_AACR]

Don't miss the interview with the recipient of the inaugural Cancer Immunology Research Award for Outstanding Journal Article—Steven A. Rosenberg, MD, PhD.
https://t.co/XJoTqpgmjw
@NCI_CCR_SB @NCIResearchCtr

[Immunology Podcast @ImmunoPodcast]

#DataSharing in science can get complicated.

Hosted by Jason and Dr. Nicole Quinn, this Lab Coats & Life Podcast episode features a discussion with Dr. Alex Shalek (@ShalekLab) about ownership, #reproducibility, & privacy concerns when sharing data. 💽

https://t.co/vmoE6jBlm3

[Wafik S. El-Deiry, MD, PhD, FACP @weldeiry]

A humanized mouse that mounts mature class-switched, hypermutated and neutralizing antibody responses

https://t.co/fSno0C7vkm

[Anirban Maitra @Aiims1742]

The Cancer-Immunity Cycle
By Ira Mellman & colleagues in @ImmunityCP
2013:
https://t.co/yCcVYLaHjY
2023 update:
https://t.co/LWighZZ0QL
(L) 2013 (R) 2023
The underlying concepts have been the capstone for a lot of modern day cancer immunotherapy research.

[Nature Reviews Drug Discovery @NatRevDrugDisc]

For readers interested in cancer immunotherapy, this review in the August issue discusses how delivery technologies such as lipid nanoparticles, hydrogels and scaffolds can reduce the clinical barriers for in situ cancer vaccines https://t.co/aaZLRwCLwB https://t.co/jXX94vBSNp

[Sade-Feldman Lab @Sade_Lab_TCI]

Kudos to my team! 🎉 Check out our protocol for dissociating multiple types of human and murine tumors, enabling successful generation of GEMs, barcoding, and sequencing. #SingleCells
https://t.co/A5rhSG7Cxu

[Cancer Cell @Cancer_Cell]

Online Now: Tumor-infiltrating lymphocytes: A new hope https://t.co/8zrX19RIxq

[Cancer Research Institute @CancerResearch]

#CICON24 isn't just a conference- it's a prime networking opportunity to connect with experts and peers. Register by July 15, and save with early-bird discounts! Don't miss this opportunity: https://t.co/Ilq7Z3uGXn #CancerResearch #Immunotherapy #CancerResearcher

[Sade-Feldman Lab @Sade_Lab_TCI]

New immunotherapy ACT uses patients’ own TILs, expanded with IL-2, to target tumor cells. Approved for advanced melanoma after showing a 31.5% cancer regression rate in a multicenter study. #CancerResearch #Melanoma #Immunotherapy

[Science Magazine @ScienceMagazine]

Earlier this year, the U.S. FDA approved the first cellular therapy for a solid cancer. This development "will stimulate both academic institutions and commercial companies to improve this therapeutic approach."

Learn more in a new #SciencePerspective: https://t.co/km8JiG6enS

[Science Magazine @ScienceMagazine]

Earlier this year, the U.S. FDA approved the first cellular therapy for a solid cancer. This development "will stimulate both academic institutions and commercial companies to improve this therapeutic approach."

Learn more in a new #SciencePerspective: https://t.co/km8JiG6enS

[EACR @EACRnews]

Highlights in Cancer Research 💡

Learn more about 'Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides':

https://t.co/FPh8Nkf48F

[Waggoner Lab @LabWaggoner]

REVIEW @SciImmunology @casanova_lab Yanick Crow
Genetic studies of type I IFN signaling reveal the narrow physiological range that is compatible with and essential for life
https://t.co/6NTSvg9Cuc

[Eric Topol @EricTopol]

New @NatureMedicine
An immunome, a metric of immune system health that recognizes marked aging in healthy adults, age-dependent antibody response to vaccines, healthy vs autoimmune or inflammatory diseases.
https://t.co/lMj1K69Vz9
@TsangLab

[Waggoner Lab @LabWaggoner]

High-throughput discovery of MHC class I- and II-restricted T cell epitopes using synthetic cellular circuits @NatureBiotech @elledge_stephen Ayano Kohlgruber
https://t.co/d4qaUdQOhe

[The Cancer Dependency Map @CancerDepMap]

📢 DepMap is hosting a webinar!
Join members of the DepMap team on Thursday, Aug 1 starting at 12pm EST to learn more about the latest DepMap release and deep dive into Data Explorer 2.0. RSVP to let us know you're attending! https://t.co/UGb5hZo6X4

[Cell Reports @CellReports]

Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy https://t.co/fiaGbxpOAp

[Science Immunology @SciImmunology]

Researchers show that cytotoxic #Tcells actively compress and pattern their targets within the #immune synapse to maximize their cell-killing potential. @huselab

Learn more in Science #Immunology: https://t.co/B3xtLJruj0

[Samantha Morris @morris_lab]

CellTag-multi is finally out in @NatureBiotech https://t.co/d2row5Ploc. We didn't make the cover this time, but I love what we put together with @DrawImpacts! Here's our fun vision of CellTag cell barcoding and capture across single-cell RNA-seq and ATAC-seq @kjkjindal